APOBEC3A and schizophrenia: TET1 expression was increased, while APOBEC3A and APOBEC3C expression was decreased in the frontal cortex of schizophrenia patients, suggesting that the disruption of the DNA methylation and demethylation pathways may contribute to elevated 5hmC levels in schizophrenia patients [87].